STING: a master regulator in the cancer-immunity cycle

Overview of attention for article published in Molecular Cancer, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 3 X users

patent: 4 patents

Citations

dimensions_citation: 235 Dimensions

Readers on

mendeley: 325 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Halogenated xanthenes as vaccine adjuvants

Grant US-11938182-B2

United States of America

EGFR INHIBITION TRIGGERS AN ADAPTIVE RESPONSE BY CO-OPTING ANTIVIRAL SIGNALING PATHWAYS…

Application EP-4106793-A4

European Patent Office

COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY

Application WO-2022223619-A1

World Intellectual Property Organisation (WIPO)

COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY

Application WO-2022223622-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.